Search Results
Aug 07, 2026, 10:09 ET AXA XL s'apprête à acquérir S-RM, un cabinet international de conseil en intelligence d'entreprise et en cybersécurité
LinkedIn.À propos d'AXA XLAXA XL, la division dédiée à l'assurance IART et aux risques spécialisés d'AXA, propose des produits et services d'assurance et de gestion des risques aux entreprises de taille intermédiaire jusqu'aux
More news about: AXA XL
Jul 09, 2026, 08:16 ET One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics
platform; P.R.O.O.F 12-month preclinical study; Ten-Minute Tissue™; anticipated 510(k) Q1 2027).Integra LifeSciences Holdings Corporation (NASDAQ: IART), Q1 2026 results and corporate disclosures, 2026.Organogenesis Holdings Inc. (NASDAQ: ORGO), Q1 2026 results and corporate disclosures, 2026.Novo Nordisk
More news about: USA News Group
Jun 02, 2026, 09:00 ET The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
between momentum and dislocation. That spread is the real backdrop for a preclinical entrant.Integra LifeSciences Holdings Corporation (NASDAQ: IART) is the established regenerative-tissue operator of the group, spanning wound surgery, surgical reconstruction, and tissue repair. On May 5 it reported
More news about: Equity Insider
May 22, 2026, 10:31 ET Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
Conexeu Sciences Inc.Companies mentioned: Conexeu Sciences Inc. (NASDAQ: CNXU), Integra LifeSciences Holdings Corporation (NASDAQ: IART), Evolus, Inc. (NASDAQ: EOLS), Bioventus Inc. (NASDAQ: BVS), Mesoblast Limited (NASDAQ: MESO)KEY TAKEAWAYSA
More news about: USA News Group